Postpartum Ward Care — Evidence-Based Practice Reference • Updated 2026
Systematic head-to-toe assessment performed every 4–8 hours on the postnatal ward. Each letter covers a key assessment domain.
| Day Postpartum | Fundal Position | Expected Finding | Action if Abnormal |
|---|---|---|---|
| Immediately after delivery | At umbilicus (U/U) | Firm, midline | If boggy: bimanual massage + oxytocin |
| Day 1 | 1 cm above umbilicus | Firm, midline | Deviated → empty bladder first |
| Day 3 | 3 cm below umbilicus | Decreasing daily | If tender + fever → endometritis |
| Day 7 | Midway to symphysis | Firm | Still large + heavy lochia → RPOC |
| Day 10–14 | Within pelvis (non-palpable) | Not palpable abdominally | Refer if still palpable at 2 weeks |
| Component | 0 (Normal) | 1–3 (Score) |
|---|---|---|
| Redness | None | Extends <0.25 cm / <0.5 cm / >0.5 cm from incision |
| Edema | None | Perineal / vulval / perineal + vulval |
| Ecchymosis | None | <0.25 cm bilateral / <1 cm bilateral / >1 cm bilateral |
| Discharge | None | Serum / bloody or purulent / purulent |
| Approximation | Closed | Skin separation 3 mm / skin + fat / all layers |
Total score 0–15. Score ≥3 warrants closer monitoring; document and escalate if deteriorating.
| Analgesic | Route/Dose | Notes |
|---|---|---|
| Paracetamol | 1 g PO/IV q6h (scheduled) | Safe in breastfeeding; first-line |
| Ibuprofen / Diclofenac | 400 mg PO q8h (scheduled) | Avoid if renal impairment; take with food |
| Opioid PRN (oral) | Codeine 30–60 mg q4–6h PRN | Caution: CYP2D6 ultra-metabolisers → neonatal sedation via BM |
| Morphine IV/IM | 5–10 mg q4h PRN (severe) | Step down to oral ASAP |
| Timeframe | Activity |
|---|---|
| 0–6 h post-LSCS | Leg exercises in bed; bed rest; deep breathing; calf pumps |
| 6–12 h | Dangle legs; sit upright; assisted stand with 2 nurses if stable |
| 12–24 h | First supervised walk to bathroom; TED stockings on |
| Day 1–2 | Independent mobilisation; increasing distance each shift |
| Day 2–5 | Independent; encourage walking the ward corridor |
| Indicator | Expected |
|---|---|
| Feed frequency | 8–12 feeds/24 h in first weeks |
| Feed duration | Variable; guided by baby (not by clock) |
| Wet nappies | 1–2/day Days 1–2; ≥6/day from Day 5 |
| Stool colour | Meconium → transitional → yellow seedy |
| Weight loss | Up to 7–10% in first week — acceptable |
| Weight gain | >20 g/day after Day 4; regain birth weight by Day 14 |
| Breast softening | Breast softer after feed = effective drainage |
Select a breastfeeding concern for evidence-based management steps:
Maternal-infant bonding may be affected by birth trauma, prematurity, PND, substance use, or psychosocial stress.
This 10-item validated scale assesses emotional wellbeing over the past 7 days. Used at 2–6 weeks postpartum. Not a diagnostic tool — always follow up with clinical assessment.
1. I have been able to laugh and see the funny side of things.
2. I have looked forward with enjoyment to things.
3. I have blamed myself unnecessarily when things went wrong.
4. I have been anxious or worried for no good reason.
5. I have felt scared or panicky for no very good reason.
6. Things have been getting on top of me.
7. I have been so unhappy that I have had difficulty sleeping.
8. I have felt sad or miserable.
9. I have been so unhappy that I have been crying.
10. The thought of harming myself has occurred to me.
| Method | Timing | Breastfeeding? | Notes |
|---|---|---|---|
| IUD (copper/hormonal) | Immediately postpartum (within 48 h) or after 4 weeks | Safe | LARC — most effective; not Day 2–28 (expulsion risk) |
| Implant (etonogestrel) | Anytime postpartum | Safe | Highly effective LARC; progestogen only |
| Progestogen-only pill (POP) | From Day 21 if not BF; anytime if BF | Safe | Must take at same time daily; no oestrogen |
| Combined OCP | Delay ≥6 weeks if BF; Day 21 if not BF | Caution | Thrombosis risk & may reduce milk supply if BF |
| DMPA (Depo-Provera) | Within 5 days or 6 weeks postpartum | Safe (after 6 weeks) | 12-week injection; delayed return of fertility |
| LAM | Postpartum whilst criteria met | Requires exclusive BF | 3 criteria: exclusive BF + amenorrhoea + <6 months = 98% effective |
| Barrier methods | After lochia settles / wound heals | Safe | Condoms: STI protection; no systemic effect |
In many GCC cultures, the mother-in-law (حماة) or maternal grandmother traditionally assumes primary childcare duties postpartum. This is viewed as supportive, not intrusive.
A widely observed tradition across GCC and Arab cultures: the mother rests for 40 days post-delivery, limiting physical activity and social obligations.
| Food/Herb | Traditional Use | Evidence / Safety |
|---|---|---|
| Ginger (زنجبيل) | Warmth, reduce lochia, prevent infection | Safe in moderate amounts; antinausea |
| Fenugreek (حلبة) | Boost milk supply — widely used in GCC | Limited RCT evidence; may cause maple syrup smell in infant; CAUTION in G6PD-deficient infants — haemolytic risk |
| Dates (تمر) | Energy, iron, uterine toning | High nutritional value; safe; good source of fibre |
| Halva / Sesame | Energy, bone strength | High calcium; safe; high calorie |
| Black seed (حبة البركة) | General wellness, milk supply | Generally safe; no strong BF evidence |
| Warm soups / broths | Hydration and recovery | Beneficial for hydration; encourage |
10 questions covering postnatal assessment, breastfeeding, mental health, post-LSCS care, and GCC context. Click an option to check your answer.